Afrikaans
Albanian
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Bosnian
Bulgarian
Catalan
Cebuano
Chichewa
Chinese (Simplified)
Chinese (Traditional)
Corsican
Croatian
Czech
Danish
Dutch
English
Esperanto
Estonian
Filipino
Finnish
French
Frisian
Galician
Georgian
German
Greek
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Korean
Kurdish (Kurmanji)
Kyrgyz
Lao
Latin
Latvian
Lithuanian
Luxembourgish
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Pashto
Persian
Polish
Portuguese
Punjabi
Romanian
Russian
Samoan
Scottish Gaelic
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sudanese
Swahili
Swedish
Tajik
Tamil
Telugu
Thai
Turkish
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
ZuluEPO Injection
EPO Injection
Ask for Catalogue
Advin Dialysis EPO Injection is a recombinant human erythropoietin used to treat anemia in patients undergoing chronic hemodialysis, by stimulating red blood cell production.
- International Quality Standard.
- Fastest Delivery.
- Export Standard Packaging.
- Customized Production.
Erythropoietin (EPO) Injection from Advin Dialysis is designed to manage anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD) in patients receiving dialysis. This recombinant human erythropoietin acts as a hormone to stimulate the bone marrow to produce more red blood cells, reducing the need for frequent blood transfusions.
Advin EPO Injection is manufactured in sterile conditions and adheres to international standards of safety and efficacy. It helps improve oxygen-carrying capacity, enhances patient vitality, and contributes to an improved quality of life during long-term dialysis care.
Advanced Features
- Recombinant human erythropoietin (rHuEPO)
- Promotes red blood cell production in dialysis patients
- Sterile, preservative-free solution
- Available in prefilled syringes or vials (e.g., 2000 IU, 4000 IU, 10000 IU)
- Reduces dependence on blood transfusions
- Enhances patient well-being and energy levels
- Compliant with pharmacopoeial and biosafety standards
- For subcutaneous or intravenous administration
Urology Division
Laparoscopy Division
Gynecology Division
Nephrology Division
Cardiology Division
